RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ...

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler ...

Improved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hard ...

The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. Amphastar's CEO and ...

However, while the market for albuterol sulfate inhalation products is substantial, with sales around $1.7 billion, it is also highly competitive with multiple existing products, both branded and ...

Sometimes a drug shortage is a nuisance. Other times, the repercussions could be more serious, as is the case with ...

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable ...

This plan should outline daily management and how to handle worsening symptoms. Carry rescue inhaler: Always have a rescue ...

Dia’s children received treatment at the Children’s Hospital of Philadelphia, where doctors were able to provide medications ...

Objectives Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in ...

There are two types of prescription asthma medicines: quick-relief and long-term control.